Article
Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes.
Neoplasia (New York, N.Y.) - 1 Jan 2021
Fernández-Blanco Beatriz, Berbegall Ana Pilar, Martin-Vañó Susana, Castel Victoria, Navarro Samuel, Noguera Rosa
Abstract excerpt
Survival in high-risk neuroblastoma (HR-NB) patients remains poor despite multimodal treatment. We aimed to identify HR-NB patients with worse outcomes by analyzing the genomic instability derived from segmental chromosomal aberrations. We calculated 3 genomic instability indexes for primary tumor SNP array profiles from 127 HR-NB patients: (1) Copy number aberration burden (%gainslength+%losseslength), (2) copy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
